EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Celestial Biolabs's enterprise value is ₹165.67 Mil.
Celestial Biolabs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.75 Mil. Therefore, Celestial Biolabs's EV-to-Revenue for today is 221.48.
The historical rank and industry rank for Celestial Biolabs's EV-to-Revenue or its related term are showing as below:
BOM:532871'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.19 Med: 1.66 Max: 268
Current: 221.48
During the past 13 years, the highest EV-to-Revenue of Celestial Biolabs was 268.00. The lowest was 0.19. And the median was 1.66.
BOM:532871's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 8.145
vs BOM:532871: 221.48
The historical data trend for Celestial Biolabs's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Celestial Biolabs's EV-to-Revenue
For the Biotechnology subindustry, Celestial Biolabs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Celestial Biolabs's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Celestial Biolabs's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Celestial Biolabs's EV-to-Revenue falls into.
Celestial Biolabs's current Enterprise Value is ₹165.67 Mil.
Celestial Biolabs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celestial Biolabs's share price for today is ₹2.02.
Celestial Biolabs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celestial Biolabs EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Celestial Biolabs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Celestial Biolabs (BOM:532871) Business Description
Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:532871 has been successfully added to your 